Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19
- Thursday, August 5, 2021, 7:13
- Finance
- Add a comment
SAN DIEGO, Aug. 5, 2021 /PRNewswire/ — Stemedica Cell Technologies, Inc. (“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announces enrollment of patients for its study entitled “A Phase II, Double-blind, Placebo-controlled…
About the Author
adminasapcorp has written 39391 stories on this site.